GAMMA Investing’s ArriVent BioPharma AVBP Stock Holding History

GAMMA Investing’s Portfolio AVBP Stock Details AVBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$15.8K	Buy	523 +88	+20%	+$2.7K	﹤0.01%	3083
2026 Q2	$15.1K	Buy	435 +76	+21%	+$2.24K	﹤0.01%	2992
2026 Q1	$8.28K	Buy	359 +214	+148%	+$4.83K	﹤0.01%	3173
2025 Q4	$2.92K	Buy	145 +60	+71%	+$1.25K	﹤0.01%	3493
2025 Q3	$1.57K	Sell	85 -14	-14%	-$275	﹤0.01%	3513
2025 Q2	$2.15K	Sell	99 -46	-32%	-$955	﹤0.01%	3382
2025 Q1	$2.68K	Buy	145 +75	+107%	+$1.83K	﹤0.01%	3323
2024 Q4	$1.86K	Buy	70 +45	+180%	+$1.29K	﹤0.01%	3241
2024 Q3	$588	Buy	25 +15	+150%	+$340	﹤0.01%	3368
2024 Q2	$186	Buy	+10	New	+$178	﹤0.01%	3359

Other funds holding AVBP

VCM

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

GAMMA Investing's AVBP Position: Q3 2026 in Review

GAMMA Investing increased its ArriVent BioPharma (AVBP) stake by 20% in Q3 2026, buying an estimated $2.7K and bringing the position to 523 shares worth $15.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3083.

GAMMA Investing first reported a position in AVBP in Q2 2024 and has held it in 10 quarters since. 4 funds tracked by Wall St. Rank hold AVBP as of Q3 2026.

GAMMA Investing held 523 shares of ArriVent BioPharma worth $15.8K as of Q3 2026.
GAMMA Investing bought 88 ArriVent BioPharma shares in Q3 2026, an estimated $2.7K.
ArriVent BioPharma made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3083 holding.
GAMMA Investing first reported a position in ArriVent BioPharma in Q2 2024 and has held it in 10 quarters since.
4 funds tracked by Wall St. Rank held ArriVent BioPharma as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.